KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Eli Lilly (LLY) over the last 16 years, with Q4 2025 value amounting to $6.6 billion.

  • Eli Lilly's Net Income towards Common Stockholders rose 5052.16% to $6.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.6 billion, marking a year-over-year increase of 9490.08%. This contributed to the annual value of $20.6 billion for FY2025, which is 9490.08% up from last year.
  • Per Eli Lilly's latest filing, its Net Income towards Common Stockholders stood at $6.6 billion for Q4 2025, which was up 5052.16% from $5.6 billion recorded in Q3 2025.
  • Eli Lilly's Net Income towards Common Stockholders' 5-year high stood at $6.6 billion during Q4 2025, with a 5-year trough of -$57.4 million in Q3 2023.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $1.8 billion (2022), whereas its average is $2.4 billion.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first plummeted by 10395.4% in 2023, then surged by 179041.81% in 2024.
  • Eli Lilly's Net Income towards Common Stockholders (Quarter) stood at $1.7 billion in 2021, then rose by 12.26% to $1.9 billion in 2022, then rose by 12.98% to $2.2 billion in 2023, then soared by 101.43% to $4.4 billion in 2024, then skyrocketed by 50.52% to $6.6 billion in 2025.
  • Its Net Income towards Common Stockholders stands at $6.6 billion for Q4 2025, versus $5.6 billion for Q3 2025 and $5.7 billion for Q2 2025.